PETERS WILLIAM J
Insider CIK 1263136 · AMPH CFO, SVP & Treasurer, Director · HITK VP and Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals, | S Sale | 2026-09-21 | 2026-09-23 | 4,139 | $25.00 | $103.5K | 168,707 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2026-09-21 | 2026-09-23 | 4,139 | $25.00 | $103.5K | 168,707 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 5,053 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2026-08-07 | 2026-08-11 | 8,180 | $22.48 | $183.9K | 172,846 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 5,053 | $19.79 | $100.0K | 181,026 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2026-08-07 | 2026-08-11 | 5,053 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2026-08-07 | 2026-08-11 | 8,180 | $22.48 | $183.9K | 172,846 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2026-08-07 | 2026-08-11 | 5,053 | $19.79 | $100.0K | 181,026 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2026-03-15 | 2026-03-17 | 1,973 | $18.18 | $35.9K | 175,063 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2026-03-10 | 2026-03-11 | 3,297 | $18.91 | $62.3K | 177,036 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2026-03-09 | 2026-03-11 | 121,071 | — | $0 | 121,071 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2026-03-09 | 2026-03-11 | 58,693 | — | $0 | 180,333 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2026-03-06 | 2026-03-10 | 2,146 | $19.34 | $41.5K | 121,640 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2026-03-04 | 2026-03-06 | 1,744 | $19.96 | $34.8K | 123,786 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2025-05-19 | 2025-05-20 | 273 | $24.79 | $6.8K | 124,985 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2025-03-17 | 2025-03-18 | 3,004 | $27.69 | $83.2K | 125,258 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2025-03-15 | 2025-03-18 | 1,968 | $26.66 | $52.5K | 128,262 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2025-03-10 | 2025-03-12 | 78,039 | — | $0 | 78,039 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2025-03-10 | 2025-03-12 | 36,747 | — | $0 | 130,230 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2025-03-06 | 2025-03-10 | 2,141 | $28.32 | $60.6K | 93,483 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2025-03-04 | 2025-03-06 | 7,490 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2025-03-04 | 2025-03-06 | 7,490 | $13.35 | $100.0K | 101,594 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2025-03-04 | 2025-03-06 | 1,739 | $27.62 | $48.0K | 95,624 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2025-03-04 | 2025-03-06 | 4,231 | $27.54 | $116.5K | 97,363 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2024-11-06 | 2024-11-08 | 7,426 | — | $0 | 23,674 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-11-06 | 2024-11-08 | 7,426 | $52.05 | $386.5K | 94,103 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2024-11-06 | 2024-11-08 | 7,426 | $13.03 | $96.8K | 101,529 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2024-07-31 | 2024-08-02 | 10,282 | — | $0 | 4,943 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2024-07-31 | 2024-08-02 | 10,282 | $20.23 | $208.0K | 104,385 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-07-31 | 2024-08-02 | 10,282 | $44.23 | $454.8K | 94,103 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-06-27 | 2024-06-28 | 2,961 | $40.85 | $121.0K | 94,738 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-06-27 | 2024-06-28 | 635 | $41.29 | $26.2K | 94,103 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2024-05-19 | 2024-05-21 | 387 | $43.48 | $16.8K | 97,268 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2024-03-17 | 2024-03-19 | 4,255 | $43.05 | $183.2K | 97,655 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2024-03-16 | 2024-03-19 | 5,105 | $43.05 | $219.8K | 101,910 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2024-03-15 | 2024-03-19 | 2,285 | $43.05 | $98.4K | 107,015 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2024-03-06 | 2024-03-08 | 8,826 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-03-06 | 2024-03-08 | 4,681 | $46.98 | $219.9K | 111,541 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2024-03-06 | 2024-03-08 | 8,826 | $11.33 | $100.0K | 129,626 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-03-06 | 2024-03-08 | 51 | $48.00 | $2.4K | 111,490 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2024-03-06 | 2024-03-08 | 2,190 | $46.31 | $101.4K | 109,300 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2024-03-06 | 2024-03-08 | 13,404 | $46.30 | $620.6K | 116,222 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 40,955 | — | $0 | 40,955 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 19,440 | — | $0 | 120,800 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-11-14 | 2023-11-16 | 21,250 | — | $0 | 15,225 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-11-14 | 2023-11-16 | 38,000 | — | $0 | 31,100 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-11-14 | 2023-11-16 | 30,162 | $55.67 | $1.68M | 116,228 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-11-14 | 2023-11-16 | 21,250 | $20.23 | $429.9K | 122,610 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-11-14 | 2023-11-16 | 38,000 | $13.03 | $495.1K | 160,610 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-11-14 | 2023-11-16 | 14,220 | $54.76 | $778.7K | 146,390 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-11-14 | 2023-11-16 | 14,868 | $56.53 | $840.5K | 101,360 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-09-06 | 2023-09-08 | 21,250 | — | $0 | 36,475 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-09-06 | 2023-09-08 | 10,000 | — | $0 | 5,053 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-09-06 | 2023-09-08 | 25,250 | — | $0 | 69,100 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-09-06 | 2023-09-08 | 25,250 | $13.03 | $329.0K | 162,103 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-09-06 | 2023-09-08 | 60,684 | $51.75 | $3.14M | 101,419 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-09-06 | 2023-09-08 | 59 | $52.26 | $3.1K | 101,360 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-09-06 | 2023-09-08 | 21,250 | $20.23 | $429.9K | 136,853 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-09-06 | 2023-09-08 | 10,000 | $19.79 | $197.9K | 115,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-06-15 | 2023-06-20 | 36,868 | — | $0 | 15,053 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-06-15 | 2023-06-20 | 36,868 | $19.79 | $729.6K | 142,471 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-06-15 | 2023-06-20 | 11,868 | $48.79 | $579.0K | 130,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-06-15 | 2023-06-20 | 13,000 | $52.79 | $686.3K | 105,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-06-15 | 2023-06-20 | 12,000 | $50.79 | $609.5K | 118,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-06-02 | 2023-06-05 | 11,000 | — | $0 | 7,490 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-06-02 | 2023-06-05 | 11,000 | $46.35 | $509.9K | 105,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-06-02 | 2023-06-05 | 11,000 | $13.35 | $146.8K | 116,603 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2023-05-19 | 2023-05-22 | 378 | $44.16 | $16.7K | 104,770 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-05-18 | 2023-05-22 | 10,500 | — | $0 | 18,490 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-05-18 | 2023-05-22 | 10,500 | $13.35 | $140.2K | 115,648 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-22 | 10,500 | $44.35 | $465.7K | 105,148 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-04-17 | 2023-04-18 | 5,632 | — | $0 | 28,990 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-04-17 | 2023-04-18 | 5,632 | $13.35 | $75.2K | 110,780 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-04-17 | 2023-04-18 | 5,632 | $42.35 | $238.5K | 105,148 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-04-13 | 2023-04-14 | 4,868 | — | $0 | 34,622 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-04-13 | 2023-04-14 | 4,868 | $13.35 | $65.0K | 110,016 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-04-13 | 2023-04-14 | 4,868 | $42.35 | $206.2K | 105,148 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-04-10 | 2023-04-12 | 10,032 | — | $0 | 39,490 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-04-10 | 2023-04-12 | 10,032 | $13.35 | $133.9K | 115,180 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-04-10 | 2023-04-12 | 10,032 | $40.35 | $404.8K | 105,148 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2023-03-17 | 2023-03-20 | 4,162 | $36.29 | $151.0K | 105,148 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2023-03-16 | 2023-03-20 | 4,995 | $37.60 | $187.8K | 109,310 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-03-15 | 2023-03-17 | 6,688 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-03-15 | 2023-03-17 | 12,776 | $36.43 | $465.4K | 118,451 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2023-03-15 | 2023-03-17 | 4,146 | $36.84 | $152.7K | 114,305 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-03-15 | 2023-03-17 | 6,688 | $14.95 | $100.0K | 131,227 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2023-03-06 | 2023-03-08 | 50,416 | — | $0 | 50,416 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2023-03-06 | 2023-03-08 | 23,925 | — | $0 | 124,539 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2023-03-01 | 2023-03-03 | 10,974 | — | $0 | 8,826 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2023-03-01 | 2023-03-03 | 10,974 | $36.33 | $398.7K | 100,614 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2023-03-01 | 2023-03-03 | 10,974 | $11.33 | $124.3K | 111,588 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-08-09 | 2022-08-10 | 10,000 | — | $0 | 49,522 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-08-09 | 2022-08-10 | 10,000 | $13.35 | $133.5K | 110,480 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-08-09 | 2022-08-10 | 10,000 | $38.35 | $383.5K | 100,480 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-06-30 | 2022-07-01 | 18,386 | — | $0 | 6,688 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-06-30 | 2022-07-01 | 18,386 | $14.95 | $274.9K | 118,866 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-06-30 | 2022-07-01 | 18,386 | $34.95 | $642.6K | 100,480 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-06-17 | 2022-06-22 | 5,512 | $32.05 | $176.7K | 100,480 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2022-05-19 | 2022-05-20 | 378 | $33.70 | $12.7K | 104,609 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2022-03-17 | 2022-03-18 | 4,162 | $34.18 | $142.3K | 104,987 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-03-16 | 2022-03-18 | 50,777 | — | $0 | 0 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-03-16 | 2022-03-18 | 3,760 | $34.36 | $129.2K | 114,144 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2022-03-16 | 2022-03-18 | 4,995 | $34.22 | $170.9K | 109,149 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-03-16 | 2022-03-18 | 47,017 | $33.93 | $1.60M | 117,904 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-03-16 | 2022-03-18 | 50,777 | $14.40 | $731.2K | 164,921 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2022-03-15 | 2022-03-17 | 50,743 | — | $0 | 50,743 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2022-03-15 | 2022-03-17 | 5,989 | $34.74 | $208.1K | 114,144 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-03-15 | 2022-03-17 | 7,900 | $34.46 | $272.2K | 98,142 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2022-03-15 | 2022-03-17 | 21,991 | — | $0 | 120,133 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-03-07 | 2022-03-09 | 13,026 | — | $0 | 59,522 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-03-07 | 2022-03-09 | 13,026 | $29.35 | $382.3K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-03-07 | 2022-03-09 | 13,026 | $13.35 | $173.9K | 119,068 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-02-25 | 2022-03-01 | 23,000 | — | $0 | 25,074 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-02-25 | 2022-03-01 | 11,000 | $27.95 | $307.4K | 118,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-02-25 | 2022-03-01 | 23,000 | $14.95 | $343.9K | 129,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-02-25 | 2022-03-01 | 12,000 | $28.95 | $347.4K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-02-08 | 2022-02-09 | 10,000 | — | $0 | 48,074 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-02-08 | 2022-02-09 | 10,000 | $26.95 | $269.5K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-02-08 | 2022-02-09 | 10,000 | $14.95 | $149.5K | 116,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-01-10 | 2022-01-11 | 16,000 | — | $0 | 50,777 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-01-10 | 2022-01-11 | 16,000 | $14.40 | $230.4K | 122,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-01-10 | 2022-01-11 | 16,000 | $25.40 | $406.4K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2022-01-07 | 2022-01-11 | 31,776 | — | $0 | 66,777 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-01-07 | 2022-01-11 | 11,776 | $24.90 | $293.2K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2022-01-07 | 2022-01-11 | 31,776 | $14.40 | $457.6K | 137,818 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2022-01-07 | 2022-01-11 | 20,000 | $24.15 | $483.0K | 117,818 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2021-12-30 | 2022-01-04 | 10,000 | — | $0 | 98,553 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-12-30 | 2022-01-04 | 10,000 | $23.40 | $234.0K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2021-12-30 | 2022-01-04 | 10,000 | $14.40 | $144.0K | 116,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2021-12-21 | 2021-12-22 | 8,256 | — | $0 | 108,553 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2021-12-21 | 2021-12-22 | 8,256 | $14.40 | $118.9K | 114,298 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-12-21 | 2021-12-22 | 8,256 | $22.40 | $184.9K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2021-12-16 | 2021-12-17 | 1,744 | — | $0 | 116,809 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-12-16 | 2021-12-17 | 1,744 | $22.40 | $39.1K | 106,042 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2021-12-16 | 2021-12-17 | 1,744 | $14.40 | $25.1K | 107,786 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2021-11-11 | 2021-11-12 | 10,000 | — | $0 | 19,800 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2021-11-11 | 2021-11-12 | 10,000 | $11.33 | $113.3K | 115,689 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-11-11 | 2021-11-12 | 10,000 | $21.33 | $213.3K | 105,689 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-08-16 | 2021-08-17 | 6,589 | $19.35 | $127.5K | 105,689 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2021-07-07 | 2021-07-08 | 10,000 | — | $0 | 29,800 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-07-07 | 2021-07-08 | 10,000 | $20.37 | $203.7K | 112,278 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2021-07-07 | 2021-07-08 | 10,000 | $11.33 | $113.3K | 122,278 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2021-05-19 | 2021-05-20 | 7,209 | — | $0 | 7,209 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2021-05-19 | 2021-05-20 | 3,047 | — | $0 | 111,349 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2021-03-17 | 2021-03-18 | 78,833 | — | $0 | 78,833 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2021-03-17 | 2021-03-18 | 33,574 | — | $0 | 108,302 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2021-03-16 | 2021-03-18 | 6,398 | $18.44 | $118.0K | 74,728 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2021-03-15 | 2021-03-17 | 4,178 | $19.15 | $80.0K | 81 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-03-15 | 2021-03-17 | 4,244 | $19.03 | $80.8K | 85,304 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2021-01-19 | 2021-01-20 | 6,495 | $18.67 | $121.3K | 89,548 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2020-08-14 | 2020-08-18 | 5,512 | $20.36 | $112.2K | 95,652 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2020-07-06 | 2020-07-08 | 10,000 | — | $0 | 39,800 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2020-07-06 | 2020-07-08 | 13,656 | $22.00 | $300.4K | 101,164 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2020-07-06 | 2020-07-08 | 10,000 | $11.33 | $113.3K | 114,820 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2020-03-17 | 2020-03-18 | 3,434 | $14.50 | $49.8K | 104,038 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2020-03-16 | 2020-03-18 | 94,350 | — | $0 | 94,350 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2020-03-16 | 2020-03-18 | 40,291 | — | $0 | 107,472 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2020-03-16 | 2020-03-18 | 2,915 | $13.03 | $38.0K | 67,181 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2020-03-15 | 2020-03-17 | 4,178 | $14.19 | $59.3K | 70,096 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2020-03-13 | 2020-03-17 | 1,737 | $14.43 | $25.1K | 74,274 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2020-03-13 | 2020-03-17 | 2,964 | $13.66 | $40.5K | 76,011 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2020-01-21 | 2020-01-23 | 3,990 | $20.07 | $80.1K | 78,975 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2019-09-16 | 2019-09-18 | 9,800 | — | $0 | 49,800 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2019-09-16 | 2019-09-18 | 9,800 | $21.76 | $213.2K | 82,453 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2019-09-16 | 2019-09-18 | 9,800 | $11.33 | $111.0K | 92,253 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2019-08-15 | 2019-08-16 | 4,942 | $21.00 | $103.8K | 82,453 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2019-03-26 | 2019-03-27 | 2,553 | $20.54 | $52.4K | 86,339 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2019-03-17 | 2019-03-19 | 5,228 | $20.23 | $105.8K | 88,892 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2019-03-16 | 2019-03-19 | 4,437 | $20.23 | $89.8K | 94,120 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2019-03-15 | 2019-03-19 | 57,725 | — | $0 | 57,725 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2019-03-15 | 2019-03-19 | 25,951 | — | $0 | 101,501 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2019-03-15 | 2019-03-19 | 2,944 | $20.23 | $59.6K | 98,557 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2019-03-04 | 2019-03-06 | 1,500 | — | $0 | 72,548 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2019-03-04 | 2019-03-06 | 1,500 | $13.35 | $20.0K | 77,050 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2019-03-04 | 2019-03-06 | 1,500 | $25.36 | $38.0K | 75,550 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2019-02-15 | 2019-02-15 | 10,016 | — | $0 | 74,048 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2019-02-15 | 2019-02-15 | 10,016 | $24.37 | $244.1K | 75,550 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2019-02-15 | 2019-02-15 | 10,016 | $13.35 | $133.7K | 85,566 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2019-01-02 | 2019-01-04 | 3,245 | $19.52 | $63.3K | 75,550 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2018-12-03 | 2018-12-04 | 10,000 | — | $0 | 59,600 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2018-12-03 | 2018-12-04 | 10,000 | $11.33 | $113.3K | 88,795 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-12-03 | 2018-12-04 | 10,000 | $22.40 | $224.0K | 78,795 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-11-12 | 2018-11-13 | 3,172 | $20.61 | $65.4K | 78,152 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2018-11-09 | 2018-11-13 | 10,000 | — | $0 | 69,600 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2018-11-09 | 2018-11-13 | 10,000 | $11.33 | $113.3K | 91,324 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-11-09 | 2018-11-13 | 10,000 | $21.47 | $214.7K | 81,324 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2018-11-08 | 2018-11-13 | 19,800 | — | $0 | 79,600 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2018-11-08 | 2018-11-13 | 19,800 | $11.33 | $224.3K | 106,636 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-11-08 | 2018-11-13 | 16,784 | $20.26 | $340.0K | 89,852 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-11-08 | 2018-11-13 | 8,528 | $20.85 | $177.8K | 81,324 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-08-16 | 2018-08-17 | 2,407 | $17.59 | $42.3K | 86,836 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-07-09 | 2018-07-11 | 3,250 | $16.46 | $53.5K | 89,243 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2018-04-21 | 2018-04-23 | 1,273 | $19.31 | $24.6K | 91,374 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2018-03-26 | 2018-03-28 | 1,677 | $18.61 | $31.2K | 92,647 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2018-03-17 | 2018-03-20 | 3,434 | $19.91 | $68.4K | 94,324 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2018-03-16 | 2018-03-20 | 2,915 | $19.91 | $58.0K | 97,758 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2018-03-15 | 2018-03-16 | 51,921 | — | $0 | 51,921 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2018-03-15 | 2018-03-16 | 22,359 | — | $0 | 100,673 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise deriv | 2018-03-13 | 2018-03-15 | 19,801 | — | $0 | 99,400 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2018-03-13 | 2018-03-15 | 19,801 | $20.10 | $398.0K | 78,314 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | M Exercise | 2018-03-13 | 2018-03-15 | 19,801 | $11.33 | $224.3K | 98,115 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2017-12-01 | 2017-12-05 | 6,226 | $19.67 | $122.5K | 78,314 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2017-10-13 | 2017-10-13 | 3,026 | $18.56 | $56.2K | 83,496 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2017-05-30 | 2017-06-01 | 4,297 | $16.93 | $72.7K | 86,522 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2017-04-21 | 2017-04-25 | 1,384 | $14.74 | $20.4K | 90,819 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2017-03-26 | 2017-03-28 | 1,823 | $13.76 | $25.1K | 92,203 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2017-03-17 | 2017-03-20 | 3,704 | $13.75 | $50.9K | 94,026 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2017-03-16 | 2017-03-20 | 84,064 | — | $0 | 84,064 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2017-03-16 | 2017-03-20 | 33,707 | — | $0 | 97,730 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2016-08-12 | 2016-08-15 | 1,027 | $18.19 | $18.7K | 63,625 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2016-07-18 | 2016-07-19 | 2,297 | $17.76 | $40.8K | 64,652 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | S Sale | 2016-06-02 | 2016-06-03 | 2,297 | $16.00 | $36.8K | 66,949 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2016-04-21 | 2016-04-22 | 1,383 | $13.05 | $18.0K | 69,246 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2016-03-26 | 2016-03-29 | 1,823 | $11.96 | $21.8K | 70,629 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2016-03-17 | 2016-03-21 | 119,201 | — | $0 | 119,201 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2016-03-17 | 2016-03-21 | 39,717 | — | $0 | 72,452 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | F Tax w/h | 2015-04-21 | 2015-04-23 | 1,384 | $15.21 | $21.1K | 32,735 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award deriv | 2015-03-26 | 2015-03-30 | 58,074 | — | $0 | 58,074 | SEC↗ |
| AMPH Amphastar Pharmaceuticals, | A Award | 2015-03-26 | 2015-03-30 | 19,397 | — | $0 | 34,119 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-10-03 | 2013-10-04 | 15,000 | — | $0 | 3,750 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-10-03 | 2013-10-04 | 6,250 | — | $0 | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-10-03 | 2013-10-04 | 6,250 | $5.83 | $36.4K | 21,250 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2013-10-03 | 2013-10-04 | 21,250 | $43.11 | $916.1K | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-10-03 | 2013-10-04 | 15,000 | $18.87 | $283.1K | 15,000 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-02-05 | 2013-02-05 | 36 | — | $0 | 12,500 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-02-05 | 2013-02-05 | 36 | $10.68 | $384 | 36 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2013-02-05 | 2013-02-05 | 36 | $38.00 | $1.4K | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-02-01 | 2013-02-05 | 4,603 | — | $0 | 12,536 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2013-02-01 | 2013-02-05 | 4,603 | $38.00 | $174.9K | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-02-01 | 2013-02-05 | 4,603 | $10.68 | $49.2K | 4,603 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-01-24 | 2013-01-28 | 6,250 | — | $0 | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2013-01-24 | 2013-01-28 | 1,611 | — | $0 | 17,139 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-01-24 | 2013-01-28 | 1,611 | $10.68 | $17.2K | 7,861 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2013-01-24 | 2013-01-28 | 7,861 | $38.00 | $298.7K | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2013-01-24 | 2013-01-28 | 6,250 | $10.68 | $66.8K | 6,250 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | A Award deriv | 2012-11-07 | 2012-11-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2012-08-15 | 2012-08-17 | 12,500 | — | $0 | 6,250 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2012-08-15 | 2012-08-17 | 12,500 | $5.83 | $72.9K | 12,500 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2012-08-15 | 2012-08-17 | 12,500 | $35.50 | $443.8K | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | A Award deriv | 2012-07-16 | 2012-07-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise deriv | 2012-07-16 | 2012-07-18 | 4,983 | — | $0 | 0 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | M Exercise | 2012-07-16 | 2012-07-18 | 4,983 | $19.95 | $99.4K | 4,983 | SEC↗ |
| HITK HI TECH PHARMACAL CO INC | S Sale | 2012-07-16 | 2012-07-18 | 4,983 | $32.00 | $159.5K | 0 | SEC↗ |